Díaz-Molina, B <br/><br/>
Effect of CYP3A5, CYP3A4, and ABCB1 genotypes as determinants of tacrolimus dose and clinical outcomes after heart transplantation.  [electronic resource] 

 -  Transplantation proceedings  Nov 2012 
 - 2635-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2623 
<br/><br/><label>Standard No.: </label>10.1016/j.transproceed.2012.09.062  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B<br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--genetics<br/>Adult<br/>Analysis of Variance<br/>Cytochrome P-450 CYP3A--genetics<br/>Diabetes Mellitus--chemically induced<br/>Female<br/>Genetic Predisposition to Disease<br/>Graft Rejection--genetics<br/>Graft Survival--drug effects<br/>Heart Transplantation--adverse effects<br/>Homozygote<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Linear Models<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Phenotype<br/>Polymorphism, Single Nucleotide<br/>Risk Assessment<br/>Risk Factors<br/>Tacrolimus--administration & dosage<br/>Treatment Outcome<br/>Young Adult